AlanWayneMD
Pediatric Hematology & Oncology • Los Angeles, CAProfessor, Pediatrics, Keck School of Medicine of the University of So California
Dr. Wayne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4650 W Sunset Blvd
Los Angeles, CA 90027Phone+1 323-361-4100Fax+1 323-361-3642- Is this information wrong?
Education & Training
Children's Hospital/Boston Medical CenterResidency, Pediatrics, 1988 - 1989
Brigham and Women's Hospital/Children's Hospital/Harvard Medical SchoolChief Residency, Internal Medicine/Pediatrics, 1987 - 1988- Brigham and Women's Hospital/Children's Hospital/Harvard Medical SchoolResidency, Internal Medicine/Pediatrics, 1985 - 1987
- Children's Hospital/Boston Medical CenterInternship, Pediatrics, 1984 - 1985
Northwestern University The Feinberg School of MedicineClass of 1984
Certifications & Licensure
FL State Medical License 1991 - 2026
CA State Medical License 2013 - 2024
MD State Medical License 1999 - 2013- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2014
Clinical Trials
- Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients Start of enrollment: 2015 Apr 08
Publications & Presentations
PubMed
- Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemi...Verma, A., Chi, Y., Malvar, J., Lamble, A., Chaudhury, S., Agarwal, A., Li, H., Liang, G., Leong, R., Brown, P., Kaplan, J., Schafer, E., Slone, T., Pauly, M., Chang, ...> ;Cancers. 2024 Jan 24
- 10 citationsThree-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.Alan S Wayne, Van Huynh, Nobuko Hijiya, Rayne H Rouce, Patrick A Brown, Joerg Krueger, Carrie L Kitko, Edward Dela Ziga, Michelle L Hermiston, Michael K Richards, Andr...> ;Haematologica. 2023 Mar 1
- 5 citationsModified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects.Francesco Ceppi, Ashley L Wilson, Colleen Annesley, Gabriella R Kimmerly, Corinne Summers, Adam Brand, Kristy Seidel, Qian Vicky Wu, Adam Beebe, Christopher Brown, Ste...> ;Cancer Immunology Research. 2022 Jul 1
- Join now to see all
Abstracts/Posters
- Cell Adhesion of ALL to Stromal Cells May Mediate CAR T-Cell Resistance: A Novel Escape Mechanism for ImmunotherapyAlan S. Wayne, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable ResponsesAlan S. Wayne, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T CellsAlan S. Wayne, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- Children’s Hospital Los Angeles Offers MIBG Therapy for NeuroblastomaJuly 14th, 2022
Hyundai Hope on Wheels Presents Children's Hospital Los Angeles with Hyundai Hope Scholar and Young Investigator Grant Totaling $500,000 to Support Pediatric Cancer ResearchSeptember 26th, 2018
Doctors in California Are Trying to Solve One Family’s Medical MysteryAugust 10th, 2018- Join now to see all
Hospital Affiliations
Children's Hospital Los AngelesLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
